CRISM developed the first national injectable opioid agonist treatment (iOAT) guideline in the world. This guideline includes two companion documents: a clinical guideline and an operational guidance document.

A synopsis of the Guideline was published in the Canadian Medical Association Journal

A podcast was also produced by CMAJ, which can be found at the link above.

You can also access the Guideline Development Methodology (as supplied by the authors) here

Supplemental Materials